According to Evolent Health's latest financial reports the company's current EPS (TTM) is -$0.70. In 2022 the company made an earnings per share (EPS) of -$0.20 an increase over its 2021 EPS that were of -$0.44.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.70 | 250% |
2022 | -$0.20 | -54.55% |
2021 | -$0.44 | -88.78% |
2020 | -$3.92 | 7.99% |
2019 | -$3.63 | 433.82% |
2018 | -$0.68 | -30.61% |
2017 | -$0.98 | -73.51% |
2016 | -$3.70 | -114.82% |
2015 | $24.97 | -2749.55% |
2014 | -$0.94 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | $2.07 | -395.71% | ๐บ๐ธ USA |
![]() Global Cord Blood CORBF | $0.64 | -191.74% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | $44.93 | -6,518.57% | ๐บ๐ธ USA |